William Pickering
Stock Analyst at Bernstein
(1.17)
# 3,742
Out of 5,044 analysts
26
Total ratings
37.5%
Success rate
-4.1%
Average return
Main Sectors:
Top Industries:
Stocks Rated by William Pickering
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| RNA Avidity Biosciences | Downgrades: Market Perform | $52 → $72 | $70.00 | +2.86% | 1 | Oct 27, 2025 | |
| REGN Regeneron Pharmaceuticals | Maintains: Outperform | $753 → $781 | $585.31 | +33.43% | 3 | Aug 27, 2025 | |
| SRPT Sarepta Therapeutics | Initiates: Market Perform | $13 | $23.50 | -44.68% | 1 | Jul 29, 2025 | |
| ALNY Alnylam Pharmaceuticals | Maintains: Outperform | $314 → $310 | $478.58 | -35.23% | 2 | Jan 7, 2025 | |
| ARWR Arrowhead Pharmaceuticals | Maintains: Market Perform | $27 → $24 | $39.48 | -39.21% | 2 | Nov 29, 2024 | |
| BHVN Biohaven | Maintains: Outperform | $55 → $66 | $17.39 | +279.53% | 2 | Sep 24, 2024 | |
| BMRN BioMarin Pharmaceutical | Maintains: Outperform | $116 → $90 | $52.67 | +70.88% | 4 | Sep 17, 2024 | |
| IONS Ionis Pharmaceuticals | Upgrades: Market Perform | n/a | $72.99 | - | 2 | Jun 14, 2024 | |
| VRTX Vertex Pharmaceuticals | Downgrades: Market Perform | n/a | $420.17 | - | 5 | Feb 2, 2024 | |
| NTLA Intellia Therapeutics | Initiates: Outperform | $54 | $14.79 | +265.11% | 1 | Mar 21, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Market Perform | $37 | $26.73 | +38.42% | 1 | Mar 21, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Market Perform | $6 | $1.23 | +387.80% | 1 | Mar 21, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Market Perform | $44 | $65.72 | -33.05% | 1 | Mar 21, 2023 |
Avidity Biosciences
Oct 27, 2025
Downgrades: Market Perform
Price Target: $52 → $72
Current: $70.00
Upside: +2.86%
Regeneron Pharmaceuticals
Aug 27, 2025
Maintains: Outperform
Price Target: $753 → $781
Current: $585.31
Upside: +33.43%
Sarepta Therapeutics
Jul 29, 2025
Initiates: Market Perform
Price Target: $13
Current: $23.50
Upside: -44.68%
Alnylam Pharmaceuticals
Jan 7, 2025
Maintains: Outperform
Price Target: $314 → $310
Current: $478.58
Upside: -35.23%
Arrowhead Pharmaceuticals
Nov 29, 2024
Maintains: Market Perform
Price Target: $27 → $24
Current: $39.48
Upside: -39.21%
Biohaven
Sep 24, 2024
Maintains: Outperform
Price Target: $55 → $66
Current: $17.39
Upside: +279.53%
BioMarin Pharmaceutical
Sep 17, 2024
Maintains: Outperform
Price Target: $116 → $90
Current: $52.67
Upside: +70.88%
Ionis Pharmaceuticals
Jun 14, 2024
Upgrades: Market Perform
Price Target: n/a
Current: $72.99
Upside: -
Vertex Pharmaceuticals
Feb 2, 2024
Downgrades: Market Perform
Price Target: n/a
Current: $420.17
Upside: -
Intellia Therapeutics
Mar 21, 2023
Initiates: Outperform
Price Target: $54
Current: $14.79
Upside: +265.11%
Mar 21, 2023
Initiates: Market Perform
Price Target: $37
Current: $26.73
Upside: +38.42%
Mar 21, 2023
Initiates: Market Perform
Price Target: $6
Current: $1.23
Upside: +387.80%
Mar 21, 2023
Initiates: Market Perform
Price Target: $44
Current: $65.72
Upside: -33.05%